Clinical Trial to Assess the Safety and Tolerability of Anti‐IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol‐Associated Liver Disease is a research paper published in Alimentary Pharmacology & Therapeutics (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AA011999
National Institutes of Health
Grant: AA028550
National Institutes of Health
Grant: DK091183
National Institutes of Health
Grant: DK099205
National Institutes of Health
Grant: DK101737
National Institutes of Health
Grant: DK120515
National Institutes of Health
Grant: P42ES010337
National Institutes of Health
Grant: R44DK115242
National Institutes of Health
Grant: R01CA285997
National Institutes of Health
Grant: R01DK111866
National Institutes of Health
Grant: R56DK088837
National Institute on Alcohol Abuse and Alcoholism
Grant: U01AA029019
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P30DK120515
National Heart, Lung, and Blood Institute
Grant: P01HL147835
National Center for Advancing Translational Sciences
Grant: 5UL1TR001442
FWCI
1.55
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals